home / stock / nevpf / nevpf message board
Subject | By | Source | When |
---|---|---|---|
Hi. I was wandering if you were invested | Chrisny73 | investorshub | 05/19/2021 5:08:32 PM |
NeuroVive Pharmaceutical AB changed to Abliva AB | Renee | investorshub | 05/29/2020 1:06:19 AM |
Just might be...thanks for the alert Chrisny73... GL...$NEVPF | Golden Cross | investorshub | 02/19/2020 7:02:34 PM |
Looks like a buying opportunity here | Chrisny73 | investorshub | 02/19/2020 6:25:00 PM |
$NEVPF Tier Change: OTCQX International to Pink Current | Golden Cross | investorshub | 01/02/2020 7:36:10 AM |
Such little volume here we won't be able | Chrisny73 | investorshub | 06/04/2019 4:17:36 PM |
cents to a dollar here..... | Chrisny73 | investorshub | 05/17/2019 5:04:51 PM |
Looking for an entry point at .10 | Chrisny73 | investorshub | 05/17/2019 5:03:05 PM |
Orphan drug huge | Chrisny73 | investorshub | 05/17/2019 5:01:29 PM |
Lotsa potential here | Chrisny73 | investorshub | 05/17/2019 4:59:37 PM |
Looking for a possible entry point at like | Chrisny73 | investorshub | 05/14/2019 4:15:35 PM |
Looks like this stock has potential.... orphan drug | Chrisny73 | investorshub | 05/14/2019 4:13:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Neurovive Pharm Ab Ord Company Name:
NEVPF Stock Symbol:
OTCMKTS Market:
LUND, Sweden, May 13, 2024 (GLOBE NEWSWIRE) -- Abliva AB (Nasdaq Stockholm: ABLI), a clinical-stage company developing drugs for the treatment of rare and severe primary mitochondrial disease, today announced that it will host a virtual KOL event on Tuesday, May 21, 2024 at 10:00 AM ET / 4:00 PM ...
Abliva AB (publ) (NEVPF) is expected to report for Q4 2023
STOCKHOLM , Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333 NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study &...